Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 across the site.
    Difference
    0.0%
    Check dated 2026-03-18T19:27:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed on the page as part of the site version update.
    Difference
    0.0%
    Check dated 2026-03-11T17:11:43.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Core trial information appears unchanged; only minor visual or formatting differences are present in the page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-18T04:41:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the lapse-in-government-funding notice and related operating-status updates were removed.
    Difference
    0.2%
    Check dated 2026-02-11T01:50:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A government funding notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T01:28:53.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a glossary and new metadata fields (Last Update Submitted that Met QC Criteria, Revision: v3.4.0) and removes older metadata (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These changes are UI and metadata tweaks and do not alter core study content or patient-facing information.
    Difference
    0.1%
    Check dated 2026-01-28T00:18:23.000Z thumbnail image

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.